Skip to content

Headache After Coil Embolization for Unruptured Intracranial Aneurysms

Comparison of Headache After Coil Embolization for Unruptured Intracranial Aneurysms (Standard Versus Stent-assisted): A Prospective Cohort Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03359252
Enrollment
190
Registered
2017-12-02
Start date
2018-06-05
Completion date
2022-10-21
Last updated
2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm, Endovascular Procedures, Headache

Keywords

coil embolization, headache, stent

Brief summary

Perform a prospective cohort study to compare the incidence and severity of headache between non-stent assisted coiling and stent assisted coiling of unruptured intracranial aneurysms.

Detailed description

severity of headache - assess with visual analogue scale characteristics of headache after stent deployment or simple coiling Duration of headache after intervention

Interventions

PROCEDUREnon-stent assisted coiling

non-stent assisted coiling of unruptured intracranial aneurysm

PROCEDUREstent assisted coiling

stent assisted coiling of unruptured intracranial aneurysm

Sponsors

Seoul National University Bundang Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

non-stent assisted coiling of unruptured intracranial aneurysms stent assisted coiling of unruptured intracranial aneurysms

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients with unruptured intracranial aneurysms * patients over 20 years old * patients who can communicate with each other * patients who agreed to this study (with informed consent)

Exclusion criteria

* patients with recurrent aneurysms after coiling or clipping * patients with allergic reaction to antiplatelets * patients with high risks of hemorrhage * patients with coagulopathy * patients with thrombocytopenia (\<100,000/mm3) * patients with liver disease (\> 100 of aspartate aminotransferase or alanine aminotransferase) * patients with renal disease (\> 2mg/dL of serum creatinine)\\ * patients with uncontrolled heart failure or angina * patients with malignant tumor * pregnant patients * patients with past history that may associated with headache, including subarachnoid hemorrhage, head trauma, intracerebral hemorrhage, trigeminal neuralgia, arteriovenous malformation, brain tumor) * Patients who are determined to be disqualified by researchers

Design outcomes

Primary

MeasureTime frameDescription
severity of headache after coil embolization between 2 armsprior to intervention / immediate after procedures / postoperative days 3, 7, 14, 90 dayscheck change of severity of headache after coil embolization between 2 arms

Secondary

MeasureTime frameDescription
Duration of headache after coiling embolization after interventionMeasure the duration of time from when a headache occurs to when it disappears, assessed up to 3 monthscheck duration of headache after coil embolization
characteristics of headache after coiling embolization between 2 armsprior to intervention / immediate after procedures / postoperative days 3, 7, 14, 90 daysidentify relationship between headache location and treated aneurysm or deployed stent

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026